Skip to main content
SpringerLink
Log in

Aim to prevent acne-induced post-inflammatory hyperpigmentation as treatment remains a challenge

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Acne-induced post-inflammatory hyperpigmentation (PIH) is a common complication of acne vulgaris in patients with darker skin and can be a cause of considerable distress. Treatment options for acne-induced PIH include topical treatments (currently the gold standard) and adjuvant procedural therapies such as chemical peels and energy-based devices. With all treatments, care needs to be taken to avoid worsening PIH. A primary strategy should be the prevention of acne-induced PIH through the effective treatment of inflammatory acne. In addition, the importance of photoprotection in preventing the worsening of PIH should not be overlooked.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168:474–85.

    Article  CAS  Google Scholar 

  2. Elbuluk N, Grimes P, Chien A, et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol. 2021;22(6):829–36.

    Article  Google Scholar 

  3. Goh CL, Abad-Casintahan F, Chow SK. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol. 2014;41:1106–8.

    Article  Google Scholar 

  4. Silpa-Archa N, Kohli I, Chaowattanapanit S, et al. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77(4):591–605.

    Article  Google Scholar 

  5. Abad-Casintahan F, Chow SK, Goh CL. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):926–8.

    Article  Google Scholar 

  6. Akinboro AO, Ezejiofor OI, Olanrewaju FO. The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates. Clin Cosmet Investig Dermatol. 2018;11:245–52.

    Article  Google Scholar 

  7. Abanmi A, Al-Enezi M, Al Hammadi A, et al. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East. J Dermatolog Treat. 2019;30:578–81.

    Article  CAS  Google Scholar 

  8. Darji K, Varade R, West D, et al. Psychosocial impact of postinflammatory hyperpigmentation in patients with acne vulgaris. J Clin Aesthet Dermatol. 2017;10(5):PMC5479473.

  9. Callender VD, Baldwin H, Cook-Bolden FE, et al. Effects of topical retinoids on acne and post-infammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol. 2022;23:69–81.

    Article  Google Scholar 

  10. Chaowattanapanit S, Silpa-Archa N, Kohli I, et al. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol. 2017;77(4):607–21.

    Article  Google Scholar 

  11. Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20–31.

    PubMed  PubMed Central  Google Scholar 

  12. Kaufman BP, Aman T, Alexis AF, et al. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19:489–503.

    Article  Google Scholar 

  13. Thomas J, Shankar K, Pujara S, et al. Consensus on management of acne-induced post-inflammatory hyperpigmentation: an Indian perspective. Int J Res Dermatol. 2021;7(2):336–45.

    Article  Google Scholar 

  14. Ishack S, Lipner SR. Exogenous ochronosis associated with hydroquinone: a systematic review. Int J Dermatol. 2021. https://doi.org/10.1111/ijd.15878.

    Article  PubMed  Google Scholar 

  15. Cook-Bolden FE, Hamilton SF. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation. Cutis. 2008;81:365-71.

  16. Cestari TF, Hassun K, Sittart A. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol. 2007;6(1):36–9.

    Article  Google Scholar 

  17. Chan R, Park KC, Lee MH, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0·05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159(3):697–703.

  18. Torok HM, Jones T, Rich P, et al. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. Cutis. 2005;75:57–62.

  19. Lowe NJ, Rizk D, Grimes P, et al. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998;20:945–59.

    Article  CAS  Google Scholar 

  20. Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10.

  21. Monteiro RC, Kishore BN, Bhat RM, et al. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013;58(2):157.

  22. Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg. 2001;25:282–4.

    Article  Google Scholar 

  23. Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328(20):1438–43.

    Article  CAS  Google Scholar 

  24. Jacyk AK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001;68:48-54.

  25. Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77:45–50.

    PubMed  Google Scholar 

  26. Sarkar R, Parmar N, Kapoor S. Treatment of postinflammatory hyperpigmentation with a combination of glycolic acid peels and a topical regimen in dark-skinned patients: a comparative study. Dermatol Surg. 2017;43(4):566–73.

    Article  CAS  Google Scholar 

  27. Sarkar R, Ghunawat S, Garg VK, et al. Comparative study of 35% glycolic acid, 20% salicylic–10% mandelic acid, and phytic acid combination peels in the treatment of active acne and postacne pigmentation. J Cutan Aesthet Surg. 2019;12(3):158–63.

    Article  Google Scholar 

  28. Ahn HH, Kim IH. Whitening effect of salicyclic acid peels in Asian patients. Dermatol Surg. 2006;32:372–5.

    CAS  PubMed  Google Scholar 

  29. Grimes PE. The safety and efficacy of salicylic acid peels in darker racial-ethnic groups. Dermatol Surg. 1999;25:18–22.

    Article  CAS  Google Scholar 

  30. Ali BMM, Gheida SF, El Mahdy NA, et al. Evaluation of salicylic acid peeling in comparison with topical tretinoin in the treatment of postinflammatory hyperpigmentation. J Cosmet Dermatol. 2017;16(1):52–60.

    Article  Google Scholar 

  31. Ejaz A, Raza N, Iftikhar N, et al. Comparison of 30% salicylic acid with Jessner’s solution for superficial chemical peeling in epidermal melasma. J Coll Physicians Surg Pak. 2008;18:205–8.

    PubMed  Google Scholar 

  32. Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76:447.

    PubMed  Google Scholar 

  33. Bae YC, Rettig S, Weiss E, et al. Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52:7–12.

    Article  Google Scholar 

  34. Wu X, Wang X, Wu X, et al. Intense pulsed light therapy improves acne-induced post-inflammatory erythema and hyperpigmentation: a retrospective study in Chinese patients. Dermatol Ther. 2022;12:1147–56.

    Article  Google Scholar 

  35. Chan HH, Manstein D, Yu CS, et al. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39:381–5.

    Article  Google Scholar 

  36. Battle EF, Hobbs LM. Laser therapy on darker ethnic skin. Dermatol Clin. 2003;21:713–23.

    Article  Google Scholar 

  37. Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013;169(Suppl 3):91–7.

    Article  Google Scholar 

  38. Thiboutot DM, Dreno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 (Suppl 1)):S1–S23.e1.

  39. Lakhdar H, Zouhair K, Khadir K, et al. Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol. 2007;21:738–42.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand

    Yvette N. Lamb

Authors
  1. Yvette N. Lamb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yvette N. Lamb.

Ethics declarations

Funding

The preparation of this review was not supported by any external funding.

Authorship and conflict of interest

Y. N. Lamb is a salaried employee of Adis International Ltd/Springer Nature and declares no relevant conflicts of interest. All authors contributed to the review and are responsible for the article content.

Ethics approval, Consent to participate, Consent for publication, Availability of data and material, Code availability

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lamb, Y.N. Aim to prevent acne-induced post-inflammatory hyperpigmentation as treatment remains a challenge. Drugs Ther Perspect 38, 343–348 (2022). https://doi.org/10.1007/s40267-022-00932-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-022-00932-8

Search

Navigation